The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...

Novo Holdings today announced that it has agreed to acquire the Norwegian fish genetics company Benchmark Genetics from Benchmark Holdings ...

Amgen Inc (NASDAQ: AMGN) says patients on its weight-loss injection in a mid-stage trial weighed up to 20% less on average ...

Guess Cuts Fiscal-Year Sales Outlook Amid Business Turnaround The apparel retailer reduced its guidance for the year after reporting that it swung to a loss in its fiscal third quarter on slower ...

Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Accelerator™ Drug Development, intended to serve biotechs and pharmas.

Investors are assessing the likelihood Trump will deliver on his threat to impose fresh tariffs on China, Canada and Mexico.

Eli Lilly has followed Novo Nordisk in announcing a big investment ... an investment of up to $100 million to increase its footprint in Germany’s early-stage biotech ecosystem.

Shares of Dye & Durham Ltd. ( DND-T +11.35% ) jumped over 11 per cent on news its chief executive officer Matt Proud, the ...